LEDERMAN SETH

CIK 00015634201 companyBERKLEY HEIGHTS, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001563420

Recent Transactions

50 trades

Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2026-02-24+134,503→ 134,503 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2026-02-24+134,504→ 134,504 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2025-05-15$21.55/sh+4,000→ 4,005 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2025-02-25+123,958→ 123,958 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2025-02-25+123,958→ 123,958 total
Other
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2025-02-05$3.38/sh−5.18→ 5 total
Other
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2025-02-05$0.15/sh−1→ 0 total
Other
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2025-02-05$3.30/sh−0.22→ 1 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-02-27+1,903,680→ 1,903,680 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-02-27+1,309,911→ 1,309,911 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-02-27+1,309,911→ 1,309,911 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-02-27+235,320→ 235,320 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-02-27+1,903,680→ 1,903,680 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2024-02-27+235,320→ 235,320 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2023-02-23+700,000→ 700,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2023-02-23+700,000→ 700,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2022-06-29$1.71/sh+20,000→ 24,235 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2022-03-25$0.24/sh+100,000→ 112,177 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2022-02-15+5,000,000→ 5,000,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2022-02-15+5,000,000→ 5,000,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2022-02-15+5,000,000→ 5,000,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2022-02-15+5,000,000→ 5,000,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2021-09-28$0.61/sh+12,000→ 12,177 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2021-03-24$1.32/sh+16,733→ 135,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2021-02-23+3,000,000→ 3,000,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2021-02-23+3,000,000→ 3,000,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2020-12-30$0.68/sh+35,000→ 118,267 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2020-08-13$0.91/sh+60,000→ 83,267 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2020-05-04+2,000,000→ 2,000,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2020-05-04+2,000,000→ 2,000,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2020-02-25+120,000→ 120,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2020-02-25+120,000→ 120,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2019-12-03$1.16/sh+20,000→ 23,267 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-05-06+129,758→ 129,758 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-05-06+129,757→ 129,757 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2019-03-29$2.49/sh+5,000→ 32,670 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2019-03-26$2.38/sh+25,000→ 27,670 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-02-26+23,265→ 23,265 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-02-26+23,265→ 23,265 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2018-06-29$4.64/sh+500→ 17,666 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2018-06-28$4.58/sh+500→ 17,166 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2018-06-27$4.55/sh+500→ 16,666 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2018-06-12$4.37/sh+1,000→ 16,166 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2018-06-12$4.37/sh+2,000→ 20,463 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2018-05-25$3.17/sh+4,000→ 26,700 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-02-13+156,601→ 156,601 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-02-13+156,601→ 156,601 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-12-26$3.61/sh+5,300→ 22,700 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-08-17$3.00/sh+15,000→ 50,000 total
Purchase
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-08-16$2.99/sh+5,000→ 35,000 total

Companies

Tonix Pharmaceuticals Holding Corp.
Director, Chief Executive Officer
$TNXP

Recent Filings

Address

C/O TONIX PHARMACEUTICALS HOLDING CORP 200 CONNEL DRIVE, SUITE 3100

BERKLEY HEIGHTS, NJ, 07922

View on SEC.gov